INTELLECTIVE

Serial Number 79376322
Registration 7636660
700

Registration Progress

Application Filed
Jun 13, 2023
Under Examination
Approved for Publication
Nov 19, 2024
Published for Opposition
Nov 19, 2024
Registered
Jan 7, 2025

Trademark Image

INTELLECTIVE

Basic Information

Serial Number
79376322
Registration Number
7636660
Filing Date
June 13, 2023
Registration Date
January 7, 2025
Published for Opposition
November 19, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 7, 2025
Registration
Registered
Classes
001 005 042

Rights Holder

Intellective Biologics (Suzhou) Co., Ltd.

99
Address
No. 96 Yinhe Road, Southeast Street
Changshu, Suzhou 215500
CN

Ownership History

NaTurtle AG

Original Applicant
25
CH

Intellective Biologics (Suzhou) Co., Ltd.

New Owner Before Publication #1
99
CN

Intellective Biologics (Suzhou) Co., Ltd.

Owner at Publication
99
CN

Intellective Biologics (Suzhou) Co., Ltd.

Original Registrant
99
CN

Legal Representation

Attorney
Stephanie Goeller

USPTO Deadlines

Next Deadline
2008 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-01-07)
Due Date
January 07, 2031
Grace Period Ends
July 07, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

29 events
Date Code Type Description
Jul 3, 2025 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Jul 3, 2025 FIMP P FINAL DISPOSITION PROCESSED
Apr 7, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 25, 2025 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 8, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 8, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 7, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 7, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER
Nov 19, 2024 PUBO A PUBLISHED FOR OPPOSITION
Nov 19, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 13, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 5, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 16, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 16, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 16, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 23, 2024 RFNT P REFUSAL PROCESSED BY IB
Apr 4, 2024 RFRR P REFUSAL PROCESSED BY MPU
Apr 4, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 3, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 2, 2024 CNRT R NON-FINAL ACTION WRITTEN
Mar 27, 2024 RFWR P NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Mar 5, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 4, 2024 CNRT R NON-FINAL ACTION WRITTEN
Mar 4, 2024 DOCK D ASSIGNED TO EXAMINER
Dec 10, 2023 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 27, 2023 CHLD M CHANGE OF OWNER RECEIVED FROM IB
Aug 15, 2023 MAFR O APPLICATION FILING RECEIPT MAILED
Aug 11, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 10, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 001
Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions; chemicals for use in industry and science; reagents for scientific apparatus for chemical or biological analyses being reagents for scientific and research use; protein in raw material form for scientific and medical research; biochemicals for in-vitro and in-vivo scientific use; biological preparations for use in industry and science; chemical preparations for use in industry; catalysts for chemical processes; diagnostic preparations for scientific use; diagnostic reagents for science or research use; stem cells for research purposes
Class 005
Pharmaceutical products for treating cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions; medical preparations for the treatment of cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions; veterinary preparations for vaccinating livestock; disinfectants; preparations for destroying vermin; fungicides; herbicides; dietetic food and beverages adapted for medical use; dietetic pet foods and beverages for veterinary use; food for babies; food supplements; medical plasters, medical dressings; medicines for treating cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions
Class 042
Research and development of new pharmaceutical products, such as antibodies, antibody-drug conjugates, fusion proteins and other recombinant proteins; providing information with respect to medical and scientific research in the field of pharmaceutical products; pharmaceutical research and development services; consultation with respect to pharmaceutical research; medical research; scientific research services for medical purposes in the field of pharmaceuticals; biomedical research services; scientific and medical research and development, namely, research and development in the field of medical preparations; design and development of testing and analysis methods for new pharmaceutical product development; scientific research in the nature of conducting clinical trials for others; analysis and evaluation of newly developed pharmaceutical products, such as antibodies, antibody-drug conjugates, fusion proteins and other recombinant proteins; analysis and evaluation of newly designed pharmaceutical products, such as antibodies, antibody-drug conjugates, fusion proteins and other recombinant proteins; stem cell research services; scientific research services for medical purposes in the field of proteins, antibodies, microorganisms and cells; product research; providing medical and scientific research information in the field of pharmaceutical products and clinical trials; providing information on the results of clinical research trials for pharmaceutical products; consultation with respect to pharmaceutical research and development; providing integrated development of pharmaceutical products, namely, research and development of pharmaceutical products, and scientific research in the nature of conducting clinical trials and studies for others

Classification

International Classes
001 005 042